1. INVESTOR RELATIONS
      Corporate Governance
      Operating income
      Operation revenue
      25.435 Billion
      Year-on-year increase
      3.71 %
      Net profit margin
      1.33 Billion
      R&D investment
      Research and development expenditure
      1.47 Billion
      Year-on-year increase
      0.59 %
      2023 Research and development expenditure
      1.462 Billion
      2022 Research and development expenditure
      0.967 Billion
      2021 Research and development expenditure
      0.81 Billion
      2020 Research and development expenditure
      0.591 Billion
      *Unit: CNY Billion
      Periodic Temporary
      Investor Interaction

      If you would like to know about investor relations, please contact us:

      ADD: No.666 Gaoxin Road, East Lake High-tech Development Zone, Wuhan, Hubei, China
      Email: renfu.pr@renfu.com.cn